Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells

Journal of Nutritional Biochemistry

Volumn 26, Issue 11, 2015, Pages 1193-1199

  Yoshino, Makiko ^a   Naka, Ayano ^a   Sakamoto, Yuri ^a   Shibasaki, Ayako ^a   Toh, Mariko ^a   Tsukamoto, Sakuka ^a   Kondo, Kazuo ^a   Iida, Kaoruko ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Daidzein; Mitochondria; Muscles; PGC1 ; Sirtuin 1

Indexed keywords

CYCLOOXYGENASE 1; CYTB PROTEIN; DAIDZEIN; ISOFLAVONE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR; PROTEIN; SHORT HAIRPIN RNA; SIRTUIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; ISOFLAVONE DERIVATIVE; POLYPHENOL; SIRT1 PROTEIN, MOUSE; TFAM PROTEIN, MOUSE; TRANSCRIPTION FACTOR NRF1;

ANIMAL CELL; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DIET; DRUG INHIBITION; DRUG POTENCY; GENE SILENCING; LUCIFERASE ASSAY; MITOCHONDRIAL GENE; MITOCHONDRION; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; BINDING SITE; CELL LINE; DIETARY SUPPLEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUSCLE MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRECLINICAL STUDY; PROCEDURES;

ANIMALS; BINDING SITES; CELL LINE; DIETARY SUPPLEMENTS; DNA-BINDING PROTEINS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; ISOFLAVONES; MICE; MITOCHONDRIA, MUSCLE; MYOBLASTS; NF-E2-RELATED FACTOR 1; OXIDATIVE PHOSPHORYLATION; POLYPHENOLS; PROMOTER REGIONS, GENETIC; SIRTUIN 1;

EID: 84946480906     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.05.010     Document Type: Article

References (47)

1. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
2. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
3. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003, 100:8466-8471.
4. Wisløff U., Najjar S.M., Ellingsen O., Haram P.M., Swoap S., Al-Share Q., et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005, 307:418-420.
5. Marzetti E., Csiszar A., Dutta D., Balagopal G., Calvani R., Leeuwenburgh C. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol 2013, 305:H459-H476.
6. Fisher R.P., Clayton D.A. Purification and characterization of human mitochondrial transcription factor 1. Mol Cell Biol 1988, 8:3496-3509.
7. Parisi M.A., Clayton D.A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 1991, 252:965-969.
8. Clayton D.A. Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol 1991, 7:453-478.
9. Freyer C., Park C.B., Ekstrand M.I., Shi Y., Khvorostova J., Wibom R., et al. Maintenance of respiratory chain function in mouse hearts with severely impaired mtDNA transcription. Nucleic Acids Res 2010, 38:6577-6588.
10. Virbasius J.V., Scarpulla R.C. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A 1994, 91:1309-1313.
11. Choi Y.S., Lee H.K., Pak Y.K. Characterization of the 5'-flanking region of the rat gene for mitochondrial transcription factor A (Tfam). Biochim Biophys Acta 2002, 1574:200-204.
12. Scarpulla R.C. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002, 286:81-89.
13. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 2002, 1576:1-14.
14. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
15. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003, 24:78-90.
16. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
17. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
18. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
19. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
20. Price N.L., Gomes A.P., Ling A.J., Duarte F.V., Martin-Montalvo A., North B.J., et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 2012, 15:675-690.
21. Brasnyó P., Molnár G.A., Mohás M., Markó L., Laczy B., Cseh J., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011, 106:383-389.
22. Hwang J.T., Kwon D.Y., Yoon S.H. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 2009, 26:17-22.
23. Ayissi V.B., Ebrahimi A., Schluesenner H. Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res 2014, 58:22-32.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
25. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
26. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
27. Rasbach K.A., Schnellmann R.G. Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 2008, 325:536-543.
28. Arunkumar E., Anuradha C.V. Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet. Nutr Res 2012, 32:617-625.
29. Davis J.M., Murphy E.A., Carmichael M.D., Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1071-R1077.
30. Feng Y., Wu J., Chen L., Luo C., Shen X., Chen K., et al. A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide. Anal Biochem 2009, 395:205-210.
31. Lorenz M. Cellular targets for the beneficial actions of tea polyphenols. Am J Clin Nutr 2013, 98:1642S-1650S.
32. Kraft C.S., LeMoine C.M., Lyons C.N., Michaud D., Mueller C.R., Moyes C.D. Control of mitochondrial biogenesis during myogenesis. Am J Physiol Cell Physiol 2006, 290:C1119-C1127.
33. Mai A., Valente S., Meade S., Carafa V., Tardugno M., Nebbioso A., et al. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J Med Chem 2009, 52:5496-5504.
34. Cantó C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
35. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407.
36. Morino K., Petersen K.F., Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55:S9-S15.
37. Sreekumar R., Halvatsiotis P., Schimke J.C., Nair K.S. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002, 51:1913-1920.
38. Bhathena S.J., Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002, 76:1191-1201.
39. Sakamoto Y., Naka A., Ohara N., Kondo K., Iida K. Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARgamma. Mol Nutr Food Res 2014, 58:718-726.
40. Fernández-Silva P., Enriquez J.A., Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003, 88:41-56.
41. Cederroth C.R., Vinciguerra M., Gjinovci A., Kuhne F., Klein M., Cederroth M., et al. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in. Diabetes 2008, 57:1176-1185.
42. Virbasius J.V., Virbasius C.A., Scarpulla R.C. Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promoters. Genes Dev 1993, 7:380-392.
43. Mootha V.K., Handschin C., Arlow D., Xie X., St Pierre J., Sihag S., et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 2004, 101:6570-6575.
44. Suetsugi M., Su L., Karlsberg K., Yuan Y.C., Chen S. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol Cancer Res 2003, 1:981-991.
45. Hirasaka K., Maeda T., Ikeda C., Haruna M., Kohno S., Abe T., et al. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation. J Nutr Sci Vitaminol (Tokyo) 2013, 59:317-324.
46. King R.A., Bursill D.B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998, 67:867-872.
47. Setchell K.D., Brown N.M., Desai P.B., Zimmer-Nechimias L., Wolfe B., Jakate A.S., et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003, 133:1027-1035.